Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

lung

[단독] Nicotine promotes breast cancer lung metastasis

[단독] Nicotine promotes breast cancer lung metastasis

[코로나 후유증] Unpredictable sequelae such as hair loss, lung fibrosis, and depression

[코로나 후유증] Unpredictable sequelae such as hair loss, lung fibrosis, and depression

MEDI:GATE NEWS ​The 31st domestic drug, Rekraza, released in 3 years, will give hope to patients with mutated lung cancer

MEDI:GATE NEWS ​The 31st domestic drug, Rekraza, released in 3 years, will give hope to patients with mutated lung cancer

Yuhan Corporation’s lung cancer treatment’Recrajajeong’ licensed…  Korean No. 31 New Drug

Yuhan Corporation’s lung cancer treatment’Recrajajeong’ licensed… Korean No. 31 New Drug

Yuhan Corporation became the 31st Korean drug for lung cancer treatment

Yuhan Corporation became the 31st Korean drug for lung cancer treatment

Acquired approval for a new drug,’Recrajajung’, a lung cancer treatment by Yuhan Corporation

Acquired approval for a new drug,’Recrajajung’, a lung cancer treatment by Yuhan Corporation

Licensed in Korea as a new drug for Lung Cancer by Yuhan Corporation.

Licensed in Korea as a new drug for Lung Cancer by Yuhan Corporation.

“Can’t prove to cause lung disease”…  ‘Humidifier disinfectant’ innocent

“Can’t prove to cause lung disease”… ‘Humidifier disinfectant’ innocent

Roche’Beting”TIGIT+PD-L1′ 1st lung cancer “designated as an innovative new drug by FDA”

Roche’Beting”TIGIT+PD-L1′ 1st lung cancer “designated as an innovative new drug by FDA”

‘Lung Cancer Fighting’ Kim Chul-min “It’s like a minefield…”

‘Lung Cancer Fighting’ Kim Chul-min “It’s like a minefield…”

‘Pogiotinib’ HER2 exon20 lung cancer “Applied for US approval next year”

‘Pogiotinib’ HER2 exon20 lung cancer “Applied for US approval next year”

Newer posts
← Previous Page1 Page2

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en